Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Clinical Study to Evaluate the Efficacy and Safety of 608 in Patients With Non-radiographic Axial Spondyloarthritis (Nr-axSpA)
Conditions
Interventions
608
608
+1 more
Locations
6
China
Site 01
Beijing, Beijing Municipality, China
Site 03
Beijing, Beijing Municipality, China
Site 05
Chongqing, Chongqing Municipality, China
Site 02
Zhengzhou, Henan, China
Site 04
Nanjing, Jiangsu, China
Site 06
Shenzhen, Shenzhen, China
Start Date
March 22, 2024
Primary Completion Date
September 22, 2025
Completion Date
November 30, 2025
Last Updated
March 11, 2025
NCT06888193
NCT05676775
NCT07339566
NCT02374749
NCT06967077
NCT06699238
Lead Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions